Verition Fund Management
FSTX

Verition Fund Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Verition Fund Management’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-187,331
Closed -$1.61M – 2438
2021
Q2 		$1.61M Buy
187,331
+58,337
+45% +$498K 0.01% 617
2021
Q1 		$1.4M Buy
+128,994
New +$1.25M 0.02% 512

Other funds holding FSTX

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Verition Fund Management's FSTX Position: Q3 2021 in Review

Verition Fund Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q3 2021, closing a stake of 187,331 shares — an estimated $1.61M sold.

Verition Fund Management first reported a position in FSTX in Q1 2021 and held it in 2 quarters. The position peaked at $1.61M in Q2 2021. 37 funds tracked by Wall St. Rank hold FSTX as of Q3 2021.

  • Verition Fund Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Verition Fund Management sold 187,331 F-star Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $1.61M.
  • Verition Fund Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Verition Fund Management's F-star Therapeutics, Inc. Common Stock position peaked at $1.61M in Q2 2021.
  • 37 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Verition Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.